Search

Your search keyword '"Park, Joong‐Won"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Park, Joong‐Won" Remove constraint Author: "Park, Joong‐Won" Database Supplemental Index Remove constraint Database: Supplemental Index
34 results on '"Park, Joong‐Won"'

Search Results

1. Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction

2. Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW.

3. Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma

5. Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma

6. Synthesis and Cytotoxicity Studies of Bioactive Benzofurans from Lavandula agustifoliaand Modified Synthesis of Ailanthoidol, Homoegonol, and Egonol

7. Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis

8. Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

9. Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study

10. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

11. Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

12. Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

13. Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area

14. Tenofovir Monotherapy versus Tenofovir plus Lamivudine or Telbivudine Combination Therapy in Treatment of Lamivudine-Resistant Chronic Hepatitis B

15. Does Postembolization Fever after Chemoembolization Have Prognostic Significance for Survival in Patients with Unresectable Hepatocellular Carcinoma?

19. Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future

20. A Novel Parvovirus Isolated from Manchurian Chipmunks

21. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

22. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

23. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

24. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

25. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

26. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

27. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

28. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

29. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

30. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

31. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

32. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

33. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

Catalog

Books, media, physical & digital resources